$1.71
0.0050.29%
Last update: 10:23 AM
15 minutes delayed
Comments
Loading...
Pacific Biosciences (PACB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPacific Biosciences (NASDAQ:PACB) Stock Quotes, Forecast and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ:PACB) through any online brokerage.
Who are Pacific Biosciences (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
What is the forecast, or price target, for Pacific Biosciences (PACB) stock?
Pacific Biosciences has a consensus price target of $5.54.
What is the current price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $1.705 last updated October 8, 2024 at 10:23 AM EDT.
Does Pacific Biosciences (PACB) pay a dividend?
There are no upcoming dividends for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, October 28, 2024.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.